KEAP1-NFE2L2 Mutations in NSCLC: Increased Awareness Needed. Reply to “KEAP1-NFE2L2–Mutant NSCLC and Immune Checkpoint Inhibitors: A Large Database Analysis”

Marco Mazzotta, Daniele Marinelli, Marcello Maugeri-Saccà

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e87-e88
JournalJournal of Thoracic Oncology
Issue number6
Publication statusPublished - Jun 2020

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this